Magnera CORP 8-K filings

Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.

NYSE
Magnera Corporation announced a record third quarter with net sales of $857 million and adjusted EBITDA of $99 million, driven by organic volume growth and synergy initiatives.
NYSE
Magnera Corporation announced its second quarter 2026 financial results, reporting net sales of $796 million and Adjusted EBITDA of $90 million, in line with expectations.
NYSE
Magnera Corporation's shareholders approved the election of nine directors, ratified Ernst & Young LLP as its auditor, and gave advisory approval to executive compensation at its 2026 Annual Meeting.
NYSE
Magnera Corporation announced strong first-quarter results, exceeding expectations with increased net sales and adjusted EBITDA, while reaffirming its fiscal year 2026 guidance.
NYSE
Magnera Corporation announced the appointment of Erin Maile as Executive Vice President, Chief Accounting Officer, effective February 2, 2026.
NYSE
Magnera Corporation announced the date for its 2026 annual shareholder meeting and key deadlines for shareholder proposals and director nominations.
NYSE
Magnera Corporation announced its fiscal year 2025 results, reporting $3.2 billion in net sales and exceeding its free cash flow target, driven by the Glatfelter merger and operational improvements.
NYSE
Magnera Corporation announced the upcoming retirements of two key executives, Eileen L. Beck and David Parks, with a slight adjustment to Mr. Parks' departure date.
NYSE
Magnera Corporation announced the upcoming departures of its Presidents for the Americas and EMEIA/APAC regions.
NYSE
Magnera Corporation reported a 51% increase in net sales to $839 million for its fiscal 2025 third quarter, driven by the Glatfelter merger, despite a GAAP net loss of $18 million.
NYSE
Magnera announces its second quarter results, highlighting net sales of $824 million and adjusted EBITDA of $89 million, while reaffirming its post-merger adjusted free cash flow range and lowering its full-year comparable adjusted EBITDA range.
NYSE
Magnera reports its first fiscal quarter results, highlighting the completion of the Berry Global merger and providing an outlook for fiscal year 2025, including adjusted EBITDA and free cash flow guidance.
NYSE
Magnera Corporation amends its previous 8-K filing to include disclosures from Spinco's Annual Report on Form 10-K, specifically focusing on risk factors and management's discussion and analysis.
NYSE
Magnera Corporation has formalized its employment agreement with CEO Curtis L. Begle, including details on his compensation and has also adopted an executive severance plan and performance share award agreement.
NYSE
Magnera Corporation files an amendment to its original 8-K report to correct a scrivener's error regarding the restricted stock unit grant to a director.
NYSE
Glatfelter Corporation and Berry Global Group Inc.'s HHNF Business have merged to form Magnera, a new global leader in the specialty materials and nonwovens industry.
NYSE
Glatfelter announced its third quarter 2024 financial results, highlighting a net sales of approximately $332 million and an adjusted EBITDA of $24.6 million, while also preparing for its merger with Berry Global's HHNF segment to form Magnera.
NYSE
Glatfelter shareholders have approved all proposals related to the merger with Berry's Health, Hygiene and Specialties Global Nonwovens and Films business, including a reverse stock split at a ratio of 1-for-13.
NYSE
Glatfelter and Berry have waived certain conditions related to tax rulings, moving closer to the completion of their planned merger.
NYSE
Glatfelter Corporation has supplemented its proxy statement/prospectus with additional disclosures to address shareholder lawsuits and demand letters related to its merger with Berry Global's HHNF business.
NYSE
Glatfelter and Berry have announced the director designees for the board of the combined company, Magnera Corporation, as they move closer to completing their merger.
NYSE
Glatfelter Corporation announced improved second quarter 2024 results with increased EBITDA and progress on its merger with Berry's HHNF business.
NYSE
Glatfelter Corporation announced the resignation of a key executive and provided updates on the ongoing merger with Berry Global's nonwovens and hygiene films business.
NYSE
Glatfelter Corporation filed an amended report to correct the signature date of its original filing regarding the results of its 2024 annual shareholder meeting.
NYSE
Glatfelter Corporation held its 2024 Annual Meeting of Shareholders, where all director nominees were elected, the appointment of Deloitte & Touche LLP was ratified, and executive compensation was approved.
NYSE
Glatfelter's first quarter of 2024 saw mixed financial results with a net loss, but improved performance in some segments, while also progressing towards a merger with Berry's HHNF business.
NYSE
Glatfelter Corporation has announced key executive appointments for the newly combined company following its merger with Berry Global's Health, Hygiene, and Specialties global nonwovens and films business.
NYSE
Glatfelter Corporation has approved a 2024 long-term incentive program for senior executives, combining equity grants and cash payments.
NYSE
Glatfelter's Q4 performance was in line with expectations, with a significant merger announcement and a full year of operational improvements despite challenging market conditions.
NYSE
Glatfelter Corporation will combine with Berry Global's nonwovens and hygiene films business through a Reverse Morris Trust transaction, creating a new entity under Glatfelter's leadership.